Bladder News and Research

RSS

Findings on molecular defects behind bladder cancer may pave way for new, targeted treatments

The once sketchy landscape of the molecular defects behind bladder cancer now resembles a road map to new, targeted treatments thanks to the unified efforts of scientists and physicians at 40 institutions.

30 Jan 2014

Bladder, lung cancers are marked by shared differences in genetics that control cell cycle

A University of Colorado Cancer Center study published in the journal PLoS ONE shows that bladder and lung cancers are marked by shared differences in the genetics that control the cell cycle.

30 Jan 2014

Researchers develop classification system to determine prognosis for bladder cancer

Researchers at Lund University have developed a classification system to determine the prognosis for bladder cancer. It is hoped that this will prove useful for future bladder cancer research and drug development.

29 Jan 2014

Serious traumatic spinal cord injuries rising among older people in the U.S.

The number of serious traumatic spinal cord injuries is on the rise in the United States, and the leading cause no longer appears to be motor vehicle crashes, but falls, new Johns Hopkins research suggests.

28 Jan 2014

Number of serious traumatic spinal cord injuries is on the rise in US, shows study

28 Jan 2014

BioTime: OncoCyte initiates clinical development of bladder cancer diagnostic test in U.S, China

BioTime, Inc. and its subsidiary OncoCyte Corporation today announced that OncoCyte has initiated clinical development of its bladder cancer diagnostic test in both the United States and China.

28 Jan 2014

Sling technique boosts post-RARP early continence recovery

Researchers have shown that addition of the bladder neck sling suspension technique to robot-assisted radical prostatectomy can improve the early return of continence after surgery.

27 Jan 2014

Cystoscopy imperative during female incontinence surgery

US researchers say that cystoscopy for lower urinary tract injury should be performed in all women undergoing urinary incontinence surgery, after finding that abnormalities are detected in one in 20 patients.

27 Jan 2014

Specialists identify opportunities to reduce unnecessary first cesarean deliveries

A recently published article, based on a workshop, Preventing the First Cesarean Delivery: Summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and the American College of Obstetricians and Gynecologists Workshop, outlines a collaboration of specialists providing obstetrical care in helping to identify opportunities to reduce unnecessary first cesarean deliveries.

25 Jan 2014

Study ultimately could lead to development of screening test for diagnosing bladder cancer

Findings from a Loyola University Medical Center study ultimately could lead to tests to screen for and diagnose bladder cancer.

22 Jan 2014

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

13 Jan 2014

HoLEP effective for overactive bladder symptoms

Research shows that Holmium laser enucleation of the prostate is effective in improving overactive bladder symptoms and urodynamic parameters in men with benign prostatic hyperplasia.

13 Jan 2014

Nonsurgical treatment improves symptoms in women with pelvic floor dysfunction

One in three women suffer from pelvic floor dysfunction, a range of symptoms which include bladder and bowel problems as well as pelvic pain, according to the American Urogynecologic Society. Now, University of Missouri researchers have demonstrated that a comprehensive, nonsurgical treatment significantly improves symptoms in women with PFD.

10 Jan 2014

Foundation Medicine announces discovery of high incidence of ERBB2 alterations in MPUC patients

Foundation Medicine, Inc. today announced the discovery of a high incidence of ERBB2 (HER2) extracellular domain alterations in patients with micropapillary urothelial carcinoma, a particularly aggressive form of urinary bladder cancer, using FoundationOne. The research was published in the current edition of Clinical Cancer Research.

10 Jan 2014

Norwegian researchers map genetic variations associated with increased risk of MS and MG

The Norwegian researchers have taken part in an international cooperative effort to map 110 genetic variations that increase the risk of MS and MG. Most of these genetic variations have been mapped in recent years.

9 Jan 2014

Mylan launches Tolterodine Tartrate ER Capsules, 2 mg and 4 mg

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.

7 Jan 2014

ERYTECH proposes to broaden lead product in solid tumors, begins Phase II study in pancreatic cancer

ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.

7 Jan 2014

New guidelines provide screening recommendations for people at higher risk of developing lung cancer

Alarmingly, more than 200,000 Americans will be diagnosed with lung cancer this year and nearly 160,000 people will die of the disease. In fact, according to the American Cancer Society, lung cancer takes more lives each year than colorectal, breast and prostate cancers combined.

7 Jan 2014

SUI and UUI show complex interrelationship

A study by US researchers has failed to identify any modifiable risk factors for urgency urinary incontinence among women undergoing surgery for stress urinary incontinence.

6 Jan 2014

Metabolon raises $15 million in Series E financing

Metabolon, Inc., a world leader in metabolomics-based diagnostic tests and research services, announced today that it has raised $15 million in a Series E financing through the issuance of preferred stock.

3 Jan 2014

Bladder News and Research

Findings on molecular defects behind bladder cancer may pave way for new, targeted treatments

Bladder, lung cancers are marked by shared differences in genetics that control cell cycle

Researchers develop classification system to determine prognosis for bladder cancer

Serious traumatic spinal cord injuries rising among older people in the U.S.

Number of serious traumatic spinal cord injuries is on the rise in US, shows study

BioTime: OncoCyte initiates clinical development of bladder cancer diagnostic test in U.S, China

Sling technique boosts post-RARP early continence recovery

Cystoscopy imperative during female incontinence surgery

Specialists identify opportunities to reduce unnecessary first cesarean deliveries

Study ultimately could lead to development of screening test for diagnosing bladder cancer

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

HoLEP effective for overactive bladder symptoms

Nonsurgical treatment improves symptoms in women with pelvic floor dysfunction

Foundation Medicine announces discovery of high incidence of ERBB2 alterations in MPUC patients

Norwegian researchers map genetic variations associated with increased risk of MS and MG

Mylan launches Tolterodine Tartrate ER Capsules, 2 mg and 4 mg

ERYTECH proposes to broaden lead product in solid tumors, begins Phase II study in pancreatic cancer

New guidelines provide screening recommendations for people at higher risk of developing lung cancer

SUI and UUI show complex interrelationship

Metabolon raises $15 million in Series E financing

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News